title: Thymic epithelial tumor progression in an SV40T transgenic mouse model. Cortical thymoma-thymic carcinoma sequence.
abstract: There have been several reports that thymoma in human is a progressive disease, and that thymoma and thymic carcinoma form a continuum. We established a stable line of SV40T transgenic mice, which consistently produced thymic epithelial tumours progressing to thymic carcinoma within a predictable time span. Using this animal model and a morphological approach, thymic epithelial tumour progression was studied with reference to sequential changes at different time points in animals aged from 3 to 32 weeks. At all ages, SV40T was expressed in the nuclei of thymic epithelial cells; in these transgenic mice we observed the entire spectrum from cortical type thymoma to thymic carcinoma. Thymic size tended to increase with ageing in SV40T TG mice. While younger mice had predominantly cortical (organoid) or cortical thymoma, older mice had well-differentiated thymic carcinoma (WDTC) or poorly differentiated thymic carcinoma. When SV40T TG mice (248 line) reached a certain age, carcinoma of the thymus was present in all of them. Cortical-type thymoma became malignant within a predictable time span, suggesting a cortical thymoma-carcinoma sequence. When the mice were 9 weeks of age, the thymuses formed gross masses compatible with cortical thymoma. At 14 weeks of age, WDTC appeared against the background of cortical thymoma. Poorly differentiated thymic carcinoma was found after 15 weeks and affected all animals over 23 weeks of age. Most thymic carcinomas coexisted in varying proportions with cortical-type thymoma. Medullary thymomas did not develop in the mice, and no transition from medullary-type thymomas to thymic carcinomas was observed. In this SV40T transgenic mouse model, thymic carcinoma is clearly preceded by cortical-type thymoma. These transgenic mice may provide an interesting model for the progression from cortical thymoma to WDTC and/or high-grade carcinoma.
authors.affiliation: Department of Pathology, Seoul National University College of Medicine, Chongno-gu, Korea. tripj@plaga.snu.ac.kr
authors.forename: S S
authors.initials: SS
authors.lastname: Lee
authors.forename: W Y
authors.initials: WY
authors.lastname: Park
authors.forename: J G
authors.initials: JG
authors.lastname: Chi
authors.forename: J W
authors.initials: JW
authors.lastname: Seo
authors.forename: J I
authors.initials: JI
authors.lastname: Kim
authors.forename: C W
authors.initials: CW
authors.lastname: Kim
authors.forename: S H
authors.initials: SH
authors.lastname: Park
authors.forename: S K
authors.initials: SK
authors.lastname: Khang
authors.forename: K J
authors.initials: KJ
authors.lastname: Cho
authors.forename: J S
authors.initials: JS
authors.lastname: Seo
authors.forename: J J
authors.initials: JJ
authors.lastname: Jang
mesh_terms: D000375:Aging; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics* / Q000378:metabolism; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D002454:Cell Differentiation; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D007124:Immunoenzyme Techniques; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D013945:Thymoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D013953:Thymus Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*
chemical_list: D000952:Antigens, Polyomavirus Transforming